Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

Market Cap	35.35B
Revenue (ttm)	2.07B
Net Income (ttm)	-1.23B
Shares Out	n/a
EPS (ttm)	-1.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,638,647
Average Volume	15,514,294
Open	36.58
Previous Close	36.62
Day's Range	36.40 - 39.03
52-Week Range	23.08 - 38.82
Beta	0.60
RSI	75.14
Earnings Date	Aug 29, 2025

About SHA:688180

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688180

Financial Performance

In 2024, SHA:688180's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.